|
|
Volumn 33, Issue 7-8, 2001, Pages 3316-3317
|
|
Effects of mycophenolate mofetil in the development of systemic lupus erythematosus in (NZBxNZW)F1 mice
a
a
a
a
b
b
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN G1;
IMMUNOGLOBULIN G2;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBODY PRODUCTION;
ANTIGEN ANTIBODY COMPLEX;
ARTICLE;
CELL MATURATION;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GLOMERULONEPHRITIS;
HISTOPATHOLOGY;
HYPERGAMMAGLOBULINEMIA;
IMMUNOGLOBULIN BLOOD LEVEL;
IMMUNOSUPPRESSIVE TREATMENT;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TH1 CELL;
ANIMALS;
ANTIBODIES, ANTINUCLEAR;
DISEASE MODELS, ANIMAL;
FEMALE;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN ISOTYPES;
IMMUNOSUPPRESSIVE AGENTS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MICE;
MICE, INBRED STRAINS;
MYCOPHENOLIC ACID;
|
|
EID: 0035670898
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02408-3 Document Type: Article |
|
Times cited : (4)
|
|
References (6)
|
